Response

We certainly appreciate the thoughtful comments of Dr  Lisotti and Dr Fusaroli1 on our article2 regarding the efficacy of contrast-enhanced EUS (CE-EUS) for differential diagnosis of lymphadenopathy. It should be emphasized, and as indicated in the article, we believe that the diagnostic capability of CE-EUS for lymphadenopathy is significantly improv ed by combining qualitative with quantitative analysis. In our study, because almost half of the malignant lymphoma showed a homogeneous enhancement pattern on CE-EUS, indicating a benign lesion, the assessment of lymphadenopathy using qualitative CE-EUS alone had limited efficacy in differentiating malignant from benign lymphadenopathy, similar to a previous study.
Source: Gastrointestinal Endoscopy - Category: Gastroenterology Authors: Tags: Letter to the Editor Source Type: research